Can Different Theories of Patent Invalidity Be Deemed Different Issues for Collateral Estoppel Purposes? READ MORE
Senate Bill and FTC 6(b) Study Turn the Heat on Pharmacy Benefit Managers Amid Drug Pricing Concerns READ MORE
Chairman Ed Haug and Partner Ben Natter Named 2022 Global Leaders for IP by Who’s Who Legal READ MORE
